Back to search

Article

Programmable bacteria induce durable tumor regression and systemic antitumor immunity

2019-03-01

Abstract excerpt

<h4>SUMMARY PARAGRAPH</h4> Synthetic biology is driving a new era of medicine through the genetic programming of living cells 1,2 . This transformative approach allows for the creation of engineered systems that intelligently sense and respond to diverse environments, ultimately adding specificity and efficacy that extends beyond the capabilities of molecular-based therapeutics 3–5 . One particular focus area h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3b27989e-44da-552b-906d-b9e8a5082c99
DOI
10.1101/561159
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Programmable bacteria induce durable tumor regression and systemic antitumor immunityDOI 10.1101/561159
In Situ Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor ResponseSemantic proximity
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodiesSemantic proximity
An immune-stimulating antibody conjugate spatiotemporally targeting CD47 and TLR9 elicits macrophage-dependent tumor clearance and durable anti-cancer adaptive immunitySemantic proximity
LIFUS-Driven Engineered Bacteria Reprogram Immunosuppressive Niches via Mechano-NOTCH SignalingSemantic proximity
Acoustic Remote Control of Bacterial ImmunotherapySemantic proximity
Microbial Systems Enhancing CAR-Based Therapies: A Synthetic Biology Paradigm for Next-Generation Cancer ImmunotherapySemantic proximity
Unlocking The Potential and Myth of Personalized Vaccines, CRISPR-CAS9, and Bacteriotherapy, as Therapeutic Options for CancerSemantic proximity
A Novel Anti-CD47 Nanobody Tetramer for Cancer TherapySemantic proximity
Programmable genetic control of tumor-colonizing Bifidobacterium longum for intratumoral therapeutic delivery and biocontainmentSemantic proximity
Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc, a key driver of tumourigenesis.Semantic proximity
Nonpathogenic E. coli engineered to surface display cytokines as a new platform for immunotherapySemantic proximity
Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium.Semantic proximity
Select a neighboring publication to make it the new centre.